肾上固定对腹主动脉瘤腔内修复术后肾功能的影响:基于估算肾小球滤过率的Meta分析
该Meta分析纳入24项研究,比较肾上固定(SRF)与肾下固定(IRF)EVAR术后肾功能损伤。1年eGFR下降>20%的加权OR为1.53(95%CI 0.67-3.51,p=.31,I²=53.2%),SRF组9.3% vs IRF组7.4%;5年eGFR相关肾功能障碍OR为1.77(95%CI 1.04-3.02,p=.03),SRF组16.9% vs IRF组10.3%;19项研究汇总肾功能障碍加权OR为1.32(95%CI 1.01-1.71,p=.03,I²=28.4%),SRF组5.1% vs IRF组4.6%。结论认为基于eGFR,SRF在1年时未导致肾功能显著下降,长期结果有限。
要点
- 1年eGFR下降>20%:SRF组9.3% vs IRF组7.4%,加权OR 1.53(95%CI 0.67-3.51,p=.31,I²=53.2%),未达统计学显著。
- 5年eGFR相关肾功能障碍:SRF组16.9% vs IRF组10.3%,OR 1.77(95%CI 1.04-3.02,p=.03)。
- 19项研究汇总肾功能障碍:SRF组5.1% vs IRF组4.6%,加权OR 1.32(95%CI 1.01-1.71,p=.03,I²=28.4%)。
核心结论
- 基于eGFR,使用SRF的EVAR在1年时未导致肾功能显著下降。
- 长期结果有限。
- 作者认为应使用eGFR而非不准确的任意指标报告长期肾损伤。
研究设计与样本
- 电子检索识别所有报告SRF与IRF EVAR术后肾损伤对比的文章,共纳入24项研究。
- 采用正式Meta分析评估1年和5年eGFR下降。
- 主要结局为1年eGFR下降>20%;次要结局包括5年eGFR下降>20%及基于各文献定义的「肾功能障碍」。
主要发现
- 5个系列报告1年eGFR下降>20%,加权OR 1.53(95%CI 0.67-3.51,p=.31,I²=53.2%),SRF组9.3% vs IRF组7.4%。
- 1项研究报告5年eGFR相关肾功能障碍,OR 1.77(95%CI 1.04-3.02,p=.03),SRF组16.9% vs IRF组10.3%。
- 19个系列报告某种形式的肾功能障碍(SRF组5287例 vs IRF组4386例,平均随访20.5个月,范围72小时至5年),加权OR 1.32(95%CI 1.01-1.71,p=.03,I²=28.4%),SRF组5.1% vs IRF组4.6%。
- 「肾功能障碍」定义差异很大,基于肌酐或其他不准确方法。
关键数值与推荐
- 1年eGFR下降>20%:SRF组9.3% vs IRF组7.4%,加权OR 1.53(95%CI 0.67-3.51,p=.31,I²=53.2%)。
- 5年eGFR相关肾功能障碍:SRF组16.9% vs IRF组10.3%,OR 1.77(95%CI 1.04-3.02,p=.03)。
- 汇总肾功能障碍:SRF组5.1% vs IRF组4.6%,加权OR 1.32(95%CI 1.01-1.71,p=.03,I²=28.4%)。
临床怎么用
- 基于eGFR,SRF在1年时未导致肾功能显著下降。
- 作者认为应使用eGFR报告长期肾损伤,而非目前文献中常见的不准确任意指标。
局限性
- 长期结果有限。
- 「肾功能障碍」定义差异很大,基于肌酐或其他不准确方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular abdominal aortic aneurysm (AAA) repair (EVAR) is currently used routinely to treat AAA. Suprarenal fixation (SRF) of EVAR grafts can lead to renal dysfunction. A meta-analysis of studies using estimated glomerular filtration rate (eGFR) as a measure of renal injury to assess the effect of SRF on renal function was performed. METHODS: An electronic search was carried out to identify all articles that reported on renal injury following SRF versus infrarenal fixation (IRF) EVAR, and 24 studies were identified. Formal meta-analysis was used to assess eGFR drop at 1 and 5 years. The primary outcome measure was a drop in eGFR >20% at 1 year; secondary measures included eGFR drop >20% at 5 years and "renal dysfunction" based on the definition used in each publication. RESULTS: Five series reported eGFR reduction >20% at 1 year. The weighted odds ratio (OR) was 1.53 (95% CI 0.67-3.51, p = .31, I2 = 53.2%); 9.3% for SRF versus 7.4% for IRF. One study reported eGFR based renal dysfunction at 5 years: OR 1.77 (95% CI 1.04-3.02, p = .03); 16.9% for SRF versus 10.3% for IRF. Nineteen series reported some form of renal dysfunction (5287 SRF vs. 4386 IRF patients, mean follow up: 20.5 months, range 72 h to 5 years). The weighted OR was 1.32 (95% CI 1.01-1.71, p = .03, I2 = 28.4%); 5.1% for SRF versus 4.6% for IRF. "Renal dysfunction" definitions varied greatly and were based on creatinine or other inaccurate methods. CONCLUSION: EVAR using SRF does not lead to a significant drop in renal function at 1 year, based on eGFR. Long-term results are limited. Authors should report long-term renal injury using eGFR and not inaccurate arbitrary measures, which are currently common in the literature.
引用
- Calderbank T, Bown M, Saratzis A, et al. The Impact of Suprarenal Fixation on Renal Function Following Endovascular Abdominal Aortic Aneurysm Repair: Meta-analysis Based on Estimated Glomerular Filtration Rate. Eur J Vasc Endovasc Surg. 2018. PMID: 29576336. doi:10.1016/j.ejvs.2018.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。